Duration of Postvaccination Neutralizing Antibodies to SARS‐CoV‐2 and Medication Effects: Results from the Safety and Immunogenicity of COVID‐19 Vaccination in Systemic Immune‐Mediated Inflammatory Diseases Cohort Study

Documenti analoghi

• Having More Tender Than Swollen Joints is Associated With Worse Function and Work Impairment in Patients With Early Rheumatoid Arthritis
  di: Charis F. Meng, et al.
  Pubblicazione: (2024)
• A Guide for Initiating and Managing Chimeric Antigen Receptor T Cell Therapy Clinical Trials in Autoimmune Rheumatic Diseases
  di: Roberto Caricchio, et al.
  Pubblicazione: (2025)
• Chronicity of Immune Checkpoint Inhibitor–Associated Inflammatory Arthritis After Immunotherapy Discontinuation: Results From the Canadian Research Group of Rheumatology in Immuno‐Oncology Database
  di: Alexandra Ladouceur, et al.
  Pubblicazione: (2025)
• Duration of Disease and Long‐Term Outcomes in Patients With Difficult‐To‐Treat Recurrent Pericarditis: A Chronic Condition Treated With Nonsteroidal Anti‐Inflammatory Drugs, Colchicine, Corticosteroids, and Anti–Interleukin‐1 Agents
  di: Elisa Ceriani, et al.
  Pubblicazione: (2025)
• A Novel Preclinical Murine Model of Systemic Lupus Erythematosus–Like Cardiovascular Disease
  di: Marice K. McCrorey, et al.
  Pubblicazione: (2024)